Cargando…
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults
INTRODUCTION: To find effective and safe treatments for COVID-19, the WHO recommended to systemically evaluate experimental therapeutics in collaborative randomised clinical trials. As COVID-19 was spreading in Europe, the French national institute for Health and Medical Research (Inserm) establishe...
Autor principal: | Ader, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507250/ https://www.ncbi.nlm.nih.gov/pubmed/32958495 http://dx.doi.org/10.1136/bmjopen-2020-041437 |
Ejemplares similares
-
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
por: Ader, Florence, et al.
Publicado: (2022) -
Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022) -
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
por: Vanden Eynde, Jean Jacques
Publicado: (2021) -
Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial
por: León López, Rafael, et al.
Publicado: (2020) -
Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol
por: Beard, Kate, et al.
Publicado: (2019)